Astromicin
Astromicin is a type of antibiotic that belongs to the aminoglycoside family. It is primarily used in the treatment of various bacterial infections. Astromicin works by inhibiting the production of proteins in bacteria, which leads to their death.
History[edit]
Astromicin was first discovered in the 1970s by a team of researchers at the Sankyo Company, a Japanese pharmaceutical company. The discovery of astromicin was a significant breakthrough in the field of pharmacology, as it offered a new way to combat resistant strains of bacteria.
Mechanism of Action[edit]
Astromicin works by binding to the ribosomes of bacteria, specifically the 30S subunit. This binding disrupts the process of protein synthesis, preventing the bacteria from growing and multiplying. As a result, the bacteria eventually die off, effectively treating the infection.
Uses[edit]
Astromicin is used to treat a variety of bacterial infections, including those caused by Gram-negative bacteria such as Pseudomonas aeruginosa and Escherichia coli. It is also effective against some Gram-positive bacteria, including certain strains of Staphylococcus aureus.
Side Effects[edit]
Like all antibiotics, astromicin can cause side effects. These may include nausea, vomiting, and diarrhea. In rare cases, astromicin can cause more serious side effects, such as kidney damage or hearing loss.
Resistance[edit]
Over time, some bacteria have developed resistance to astromicin. This resistance is often due to mutations in the bacteria's ribosomal proteins, which prevent astromicin from binding effectively. To combat this resistance, researchers are continually developing new variations of astromicin.
See Also[edit]
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
